XML 61 R42.htm IDEA: XBRL DOCUMENT v3.6.0.2
Fair value measurement (Tables)
12 Months Ended
Dec. 31, 2016
Fair Value Disclosures [Abstract]  
Fair value of each major class of financial assets and liabilities measured at fair value on a recurring basis
The fair value of each major class of the Company’s financial assets and liabilities measured at fair value on a recurring basis was as follows (in millions):
Fair value measurement as of December 31, 2016, using:
 
Quoted prices in
active markets for
identical assets
(Level 1)
 
Significant other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
Total
Assets:
 
 
 
 
 
 
 
 
Available-for-sale investments:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
$
6,614

 
$

 
$

 
$
6,614

Other government-related debt securities:
 
 
 
 
 
 
 
 
U.S.
 

 
299

 

 
299

Foreign and other
 

 
1,759

 

 
1,759

Corporate debt securities:
 
 
 
 
 
 
 
 
Financial
 

 
8,460

 

 
8,460

Industrial
 

 
8,789

 

 
8,789

Other
 

 
1,077

 

 
1,077

Residential mortgage-backed securities
 

 
1,940

 

 
1,940

Other mortgage- and asset-backed securities
 

 
1,719

 

 
1,719

Money market mutual funds
 
2,782

 

 

 
2,782

Other short-term interest-bearing securities
 

 
4,188

 

 
4,188

Equity securities
 
154

 

 

 
154

Derivatives:
 

 

 

 

Foreign currency contracts
 

 
203

 

 
203

Interest rate swap contracts
 

 
41

 

 
41

Total assets
 
$
9,550

 
$
28,475

 
$

 
$
38,025

Liabilities:
 
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
 
Foreign currency contracts
 
$

 
$
4

 
$

 
$
4

Cross-currency swap contracts
 

 
523

 

 
523

Interest rate swap contracts
 

 
7

 

 
7

Contingent consideration obligations in connection with business combinations
 

 

 
179

 
179

Total liabilities
 
$

 
$
534

 
$
179

 
$
713

Fair value measurement as of December 31, 2015, using:
 
Quoted prices in
active markets for
identical assets
(Level 1)
 
Significant  other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
 
Total
Assets:
 
 
 
 
 
 
 
 
Available-for-sale investments:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
$
4,274

 
$

 
$

 
$
4,274

Other government-related debt securities:
 
 
 
 
 
 
 
 
U.S.
 

 
534

 

 
534

Foreign and other
 

 
1,739

 

 
1,739

Corporate debt securities:
 
 
 
 
 
 
 
 
Financial
 

 
7,871

 

 
7,871

Industrial
 

 
7,836

 

 
7,836

Other
 

 
885

 

 
885

Residential mortgage-backed securities
 

 
1,470

 

 
1,470

Other mortgage- and asset-backed securities
 

 
2,469

 

 
2,469

Money market mutual funds
 
3,370

 

 

 
3,370

Other short-term interest-bearing securities
 

 
528

 

 
528

Equity securities
 
136

 

 

 
136

Derivatives:
 

 

 

 

Foreign currency contracts
 

 
142

 

 
142

Interest rate swap contracts
 

 
71

 

 
71

Total assets
 
$
7,780

 
$
23,545

 
$

 
$
31,325

Liabilities:
 
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
 
Foreign currency contracts
 
$

 
$
8

 
$

 
$
8

Cross-currency swap contracts
 

 
250

 

 
250

Interest rate swap contracts
 

 
3

 

 
3

Contingent consideration obligations in connection with business combinations
 

 

 
188

 
188

Total liabilities
 
$

 
$
261

 
$
188

 
$
449

Change in carrying amounts of contingent consideration obligations
Changes in the carrying amounts of contingent consideration obligations were as follows (in millions):
 
During the years ended December 31,
 
2016
 
2015
Beginning balance
$
188

 
$
215

Additions from Dezima acquisition

 
110

Payment to former BioVex Group, Inc. shareholders

 
(125
)
Net changes in valuation
(9
)
 
(12
)
Ending balance
$
179

 
$
188